News

Sunbird Bio Presents New Clinical Data Demonstrating Proprietary Alpha Synuclein Blood-Based Biomarkers Could Accurately Diagnose Parkinson’s Disease

Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders

Sunbird Bio Presents Latest Data Reinforcing Significance of Blood-Based Tau Biomarkers in the Accurate Diagnosis of Alzheimer’s Disease